Clinical Trials Directory

Trials / Completed

CompletedNCT03041532

Impact of Proximal Colon Retroflexion in Colorectal Cancer Screening Programme

Impact of Proximal Colon Retroflexion in Colorectal Cancer Screening Programme: Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
692 (actual)
Sponsor
Hospital del Rio Hortega · Academic / Other
Sex
All
Age
50 Years – 69 Years
Healthy volunteers
Not accepted

Summary

Colorectal cancer (CRC) is the most common tumor and the second leading cause of death in the Western world. The decrease in incidence and mortality by CRC in the population undergoing screening has been observed. Colonoscopy is the recommended method for detecting tumors in early stages, as well as identifying and resecting adenomatous polyps, which are the precursor lesions of most CRCs. Colonoscopy should be of high quality to decrease incidence and mortality by CRC and avoid interval cancer. The literature shows that colonoscopy does not prevent right colon lesions in the same way as the left colon lesions, with most of the interval cancers located in the right colon. Studies published so far show an increase in the adenomas detection rate (ADT) in the right colon in the second visualization of this segment and an increase between 2 and 10% if this second examination is performed with the proximal retroflexion maneuver.Retroflexion is a safe maneuver in expert endoscopists. The aim of our study is to evaluate the ADT in the right colon by means of a second visualization by performing proximal retroflexion or second frontal visualization at random in the CCR screening population.

Conditions

Interventions

TypeNameDescription
PROCEDUREProximal retroflexionThe investigator explore twice right colon, first front view and second forward viewing or proximal retroflexion depends on randomization
PROCEDUREFrontal viewThe investigator explore twice right colon with frontal viewing

Timeline

Start date
2017-10-01
Primary completion
2018-10-30
Completion
2018-11-30
First posted
2017-02-02
Last updated
2020-02-19

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03041532. Inclusion in this directory is not an endorsement.